Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: Results of a randomised phase III trial on dose response (EORTC trial 22844)
Kiebert, GM × Curran, D Aaronson, NK Bolla, M Menten, Johan Rutten, EHJM Nordman, E Silvestre, ME Pierart, M Karim, ABMF #
Pergamon-elsevier science ltd
European journal of cancer vol:34 issue:12 pages:1902-1909
In 1985, the EORTC Radiotherapy Go-operative Group launched a randomised phase III study comparing high-dose (59.4 Gy in 6.5 weeks) versus law-dose (45 Gy in 5 weeks) radiotherapy with conventional techniques in patients diagnosed with low-grade cerebral glioma. The primary endpoint of the study was survival. No difference in survival was observed between the two treatment strategies, A quality of Life (QoL) questionnaire consisting of 47 items assessing a range of physical, psychological, social, and symptom domains was included in the trial to measure the impact of treatment over time. Patients who received high-dose radiotherapy tended to report lower levels of functioning and more symptom burden following completion of radiotherapy. These group differences were statistically significant for fatigue/malaise and insomnia immediately after radiotherapy and in leisure time and emotional functioning at 7-15 months after randomisation. These findings suggest that: for conventional radiotherapy for low-grade cerebral glioma, a schedule of 45 Gy in 5 weeks not only saves valuable resources, but also spares patients a prolonged treatment at no loss of clinical efficacy. (C) 1998 Elsevier Science Ltd. All rights reserved.